相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。EGFR-Driven Mutation in Non-Small-Cell Lung Cancer (NSCLC) Influences the Features and Outcome of Brain Metastases
Daniele Armocida et al.
JOURNAL OF CLINICAL MEDICINE (2023)
Brain Metastasis-a Distinct Oncologic Disease Best Served by an Integrated Multidisciplinary Team Approach
Nelson S. Moss et al.
JAMA ONCOLOGY (2022)
Surgery for brain metastases - real-world prognostic factors' association with survival
Rebecca Rootwelt Winther et al.
ACTA ONCOLOGICA (2021)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
E. Le Rhun et al.
ANNALS OF ONCOLOGY (2021)
Mortality, Morbidity, and Prognostic Factors in the Surgical Resection of Brain Metastases: A Contemporary Cohort Study
Helder Picarelli et al.
JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY (2020)
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient
Paul W. Sperduto et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Survival and prognostic factors in surgically treated brain metastases
Vasileios K. Kavouridis et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Treatment of Adults With Metastatic Brain Tumors: Executive Summary
Jeffrey J. Olson et al.
NEUROSURGERY (2019)
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors
Laurie E. Gaspar et al.
NEUROSURGERY (2019)
Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases
Emily Schapira et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V. Long et al.
LANCET ONCOLOGY (2018)
Postoperative local fractionated radiotherapy for resected single brain metastases
Ahmad Walid Ayas et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2018)
Two-year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre
Daniel Loh et al.
BRITISH JOURNAL OF NEUROSURGERY (2018)
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial
Paul D. Brown et al.
LANCET ONCOLOGY (2017)
Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial
Anita Mahajan et al.
LANCET ONCOLOGY (2017)
Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
Riccardo Soffietti et al.
NEURO-ONCOLOGY (2017)
Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study
Daniel N. Cagney et al.
NEURO-ONCOLOGY (2017)
Prognostic factors in patients treated with surgery for brain metastases: A single-center retrospective analysis of 125 patients
Zhenghao Liu et al.
INTERNATIONAL JOURNAL OF SURGERY (2017)
Brain Metastases: Surgical Treatment and Overall Survival
Giancarlo D'Andrea et al.
WORLD NEUROSURGERY (2017)
Neurosurgical management of brain metastases
Sherise D. Ferguson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Discordance of Mutation Statuses of Epidermal Growth Factor Receptor and K-ras between Primary Adenocarcinoma of Lung and Brain Metastasis
Kun-Ming Rau et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases A Randomized Clinical Trial
Paul D. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
Paula Mulvenna et al.
LANCET (2016)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement
Gary S. Collins et al.
BMC MEDICINE (2015)
Differences in Performance Status Assessment Among Palliative Care Specialists, Nurses, and Medical Oncologists
Yu Jung Kim et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)
The role of surgical resection in the management of brain metastasis: a 17-year longitudinal study
Chang-Hyun Lee et al.
ACTA NEUROCHIRURGICA (2013)
ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer
Matthias Preusser et al.
LUNG CANCER (2013)
Presentation, Patterns of Care, and Survival in Patients With Brain Metastases What Has Changed in the Last 20 Years?
Carsten Nieder et al.
CANCER (2011)
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
Eric L. Chang et al.
LANCET ONCOLOGY (2009)
Quality of Life in Brain Metastases Radiation Trials: A Literature Review
Edward Chow et al.
Current Oncology (2008)
A new prognostic index and comparison to three other indices for patients with brain metastases: An analysis of 1,960 patients in the RTOG database
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Comparison of the epidermal growth factor receptor gene and protein in primary non-small-cell-lung cancer and metastatic sites: implications for treatment with EGFR-inhibitors
A Italiano et al.
ANNALS OF ONCOLOGY (2006)